Rhinomed Limited Stock Market Press Releases and Company Profile
CEO Presentation at Onemed Forum
CEO Presentation at Onemed Forum

Sydney, Jan 13, 2015 AEST (ABN Newswire) - Rhinomed Ltd (googlechartASX:RNO) Rhinomed CEO Presentation at Onemed Forum.

WHO IS RHINOMED?

- A nasal and respiratory medical technology company based in Melbourne, Australia

- Rhinomed develops, markets and partners it's internal nasal technology platform into multiple form factors - internal nasal devices

- Focus is unmet needs in sport & exercise, sleep (snoring, sleep quality and sleep apnea), wellness and drug delivery

- Launched first product in February 2014, now shipping to 36 countries

- Second product released prior to Christmas

- Raised $7.5m to date

- Market Cap- AUD$13m, CY14 revenue - $527,000

- Listed: Australian Stock Exchange (googlechartASX:RNO)

- Experienced Board and team including biotech execs and former European CEO of Nike

To view the presentation, including details on the benefits of the MuteSnoring and the Turbine products, please visit:
http://media.abnnewswire.net/media/en/docs/ASX-RNO-417694.pdf


About Rhinomed Limited

Rhinomed Limited ASX:RNO

Rhinomed Limited (ASX:RNO) is a Melbourne based technology firm with a focus on nasal, respiratory and breathing management technologies. The company is seeking to monetise applications of its technology portfolio in the Sport, Sleep, Wellbeing and Drug Delivery markets. For more information, go to www.rhinomed.global

TwitterFollow the Turbine on Twitter at @theturbinecom
Follow Mute Snoring on Twitter at @mutesnoring

https://plus.google.com/112881158738803317960 https://twitter.com/rhinomedceo https://www.facebook.com/Rhinomed https://www.youtube.com/channel/UCU_Op9p0A1e4FW5jCPzA2Ww https://www.linkedin.com/company/rhinomed-limited-australia abnnewswire.com 


Contact

Rhinomed Ltd
Michael Johnson, CEO
T: +61-3-8416-0900
F: +61-3-8080-0796
E: mjohnson@rhinomed.com.au
WWW: www.rhinomed.com.au



ABN Newswire
ABN Newswire This Page Viewed:  (Last 30 Days: 14) (Since Published: 5105)